STAT
JUNE 30, 2025
American medical research is a unique source of national pride and reputation — some would say the United States’ most important export. Yet Secretary of Health and Human Services Robert F. Kennedy Jr. seems bent on destroying our greatest successes. As the latest strike, Kennedy is going after the publications that disseminate medical research.
Pharma Times
JUNE 30, 2025
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs UCB reports success in phase 3 study of fenfluramine for CDD by John Pinching | 30th Jun 2025 | News Positive trial results offer hope for those with ultra-rare epileptic disorder UCB has announced that its phase 3 trial evaluating fenfluramine in CDKL5 deficiency disorder (CDD) achieved its primary and
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JUNE 30, 2025
WASHINGTON — The Department of Health and Human Services will renew funding to states for cancer prevention and tracking efforts, alleviating anxieties among local officials about the future of their work. Over 50 notices had gone out as of Monday, an HHS spokesperson said. The rest of the awards will be sent to states, tribes, and other contractors “no later than early next week,” press secretary Emily Hilliard told STAT in an email.
Beckers Hospital Review
JUNE 30, 2025
The Justice Department, through its 2025 National Health Care Fraud Takedown investigation, has charged 324 defendants in schemes involving more than $14.6 billion in intended losses to Medicare, Medicaid and other government programs. Five things to know: 1. The 2025 operation was the largest in the department’s history, more than double the previous record of $6 billion, according to a June 30 department news release. 2.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
JUNE 30, 2025
AbbVie said Monday that it would pay up to $2.1 billion to acquire Capstan Therapeutics , a startup developing CAR-T therapies for autoimmune conditions, fibrosis, and cancer. AbbVie will pay up to $2.1 billion in cash when the deal closes, according to a press release. The companies did not give further details about the financial terms or a timeline for completing the acquisition.
Express Pharma
JUNE 30, 2025
The Institute of Chemical Technology (ICT), Mumbai, announces the selection of Dr Prajakta Dandekar Jain, UGC Assistant Professor, Department of Pharmaceutical Sciences and Technology, as a Founding Member of the newly constituted INSA Women Associates (IWA) by the Indian National Science Academy (INSA), New Delhi. This recognition celebrates Dr. Jain’s contributions in the field of pharmaceutical biotechnology and her unwavering commitment to mentorship, interdisciplinary collaboration, and ad
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
JUNE 30, 2025
With tariffs looming, Indian drugmaker Hikma has said it will spend $1bn to expand its manufacturing and R&D operations in the US by 2030.
STAT
JUNE 30, 2025
A new blood test could predict preeclampsia as early as the first trimester. In a new study, researchers successfully predicted the early-onset subtype of the prenatal condition up to five months before clinical diagnosis. The findings are being presented Monday during the annual meeting of the European Society of Human Reproduction and Embryology, in Paris.
pharmaphorum
JUNE 30, 2025
There is enough experience with the first wave of autologous CAR-T therapies to allow strict rules ensuring their safe use to be relaxed, says FDA.
STAT
JUNE 30, 2025
ASPEN, Colo. — When Jessica Owens was toiling away in graduate school, she didn’t know what a venture capitalist was, much less that she’d one day launch her own firm and raise its inaugural $45 million fund. Owens co-founded Initiate Ventures, a Bay Area VC firm, after a winding career that spans roles at the Centers for Disease Control and Prevention and a stint in a cancer biology Ph.D. program before she ditched the lab to explore the world of finance.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
JUNE 30, 2025
Neopharmed Gentili buys BioCryst's hereditary angioedema drug Orladeyo in Europe, the first stage of an international expansion for the Italian firm.
Beckers Hospital Review
JUNE 30, 2025
The Federal Trade Commission has approved UPS’ $1.6 billion acquisition of Andlaur Healthcare Group, a Canadian provider of temperature-controlled logistics and distribution services for the healthcare sector. The green light allows UPS to proceed with the transaction first announced in April, as the company continues to deepen its push into healthcare logistics.
STAT
JUNE 30, 2025
The U.S. Supreme Court has declined to review an appeals court ruling that struck down key parts of an Oklahoma law regulating the retail networks created by pharmacy benefit managers, a victory for the controversial middlemen in the pharmaceutical supply chain that may create uncertainty across the country. The law, which was enacted in 2019, was designed to ensure that pharmacy benefit managers maintain access to a large number of pharmacies and do not steer patients to favored outlets, among
Beckers Hospital Review
JUNE 30, 2025
A growing number of small and rural hospitals are delaying cybersecurity improvements due to looming Medicaid funding cuts, according to a June 30 report from Black Book Research. The survey of 187 leaders at hospitals with fewer than 150 beds found that 25% of U.S. hospitals are vulnerable to cyberattacks because of staffing shortages, outdated technology and low cybersecurity budgets.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
FDA Law Blog: Biosimilars
JUNE 30, 2025
By Larry K. Houck — A memorable Florida Orange Growers’ television ad campaign in the late 1970s proclaimed that “Orange juice from Florida isn’t just for breakfast anymore.” The Federal Controlled Substances Act (“CSA”) and its regulations require Drug Enforcement Administration (“DEA”) registrants to submit certain reports related to narcotic drug transactions, thefts and significant losses, and suspicious orders.
Beckers Hospital Review
JUNE 30, 2025
Kansas City, Mo.-based St. Luke’s Health System has launched outbound pharmacy delivery from its new Consolidated Service Center, centralizing medication distribution to 14 acute care and St. Luke’s Cancer Institute pharmacy locations as of June 19. The rollout marks the first phase of a broader shift toward a more integrated pharmacy operation, according to a June 27 LinkedIn post from Kelley Curtis, PharmD, vice president and chief pharmacy officer at St.
Express Pharma
JUNE 30, 2025
Alembic Pharmaceuticals announced that it has received final approval from the United States Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Doxorubicin Hydrochloride Liposome Injection. The approval includes 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) single-dose vials. The product is therapeutically equivalent to the reference listed drug (RLD), Doxil Liposome Injection, in the same strengths, marketed by Baxter Healthcare Corporation.
STAT
JUNE 30, 2025
Sage Therapeutics is laying off most of its employees after announcing its planned acquisition earlier this month. The Cambridge, Mass.-based biotech firm will cut 338 jobs effective Aug. 22, according to state filings. In February, the company reported employing 353 full-time staff, including 122 working in research and development. Notice of the layoffs, filed on June 26, came less than two weeks after Sage announced it would be acquired by Maryland-based Supernus Pharmaceuticals in
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Big Molecule Watch
JUNE 30, 2025
On June 25, 2025, Kashiv BioSciences announced positive topline results from its confirmatory Phase 3 trial of ADL-018, a proposed biosimilar to XOLAIR® (omalizumab), in patients with chronic spontaneous urticaria. The study met both primary and secondary endpoints, demonstrating therapeutic equivalence and comparable safety to the reference product.
Express Pharma
JUNE 30, 2025
The Romaco Group has been awarded its first-ever gold medal in the EcoVadis sustainability ratings, scoring 80 out of a possible 100 points. This result puts the international group of companies in the top 2 per cent of all suppliers assessed. Following the silver medal the group won in 2023, gold represents a great success for the manufacturer of processing and packaging technologies.
Commonwealth Pharmacists Association
JUNE 30, 2025
Skip to content Who We Are CPA President & Vice President CPA Council CPA Team Alliances Member Associations Partners Patrons Fellows Strategy Our Impact Join Careers Our Work AMR COVID-19 CPD PharmAid Tools and Resources Latest Events News Blog Publications Support Us Contact Menu Who We Are CPA President & Vice President CPA Council CPA Team Alliances Member Associations Partners Patrons Fellows Strategy Our Impact Join Careers Our Work AMR COVID-19 CPD PharmAid Tools and Resources L
Pharmafile
JUNE 30, 2025
The US Food and Drug Administration (FDA) has approved Gamifant (emapalumab-lzsg) for the treatment of macrophage activation syndrome (MAS) in adult and paediatric patients with known or suspected Still’s disease, including systemic juvenile idiopathic arthritis. Announced by biopharma company Sobi, the approval makes Gamifant the first-ever FDA-approved therapy for MAS.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
pharmaphorum
JUNE 30, 2025
INmune Bio's bid to develop an Alzheimer's drug with a new mechanism of action has been dented, but the company remains upbeat
Pharmaceutical Business Review
JUNE 30, 2025
This agreement grants Qilu exclusive rights to develop, manufacture, enhance, utilise and commercialise Albipagrastim alfa for Injection in Greater China including Chinese Mainland, Macau, Hong Kong and Taiwan. T-mab will potentially receive up to 500m yuan ($69m) upfront payment and sales milestones, along with royalties on net sales. Albipagrastim alfa is a recombinant human serum albumin (HAS) or human granulocyte-colony stimulating factor (I) (G-CSF) fusion protein.
Beckers Hospital Review
JUNE 30, 2025
The FDA has eliminated Risk Evaluation and Mitigation Strategies for all currently approved BCMA- and CD19-directed autologous CAR-T cell immunotherapies, determining that the safety program is no longer necessary to ensure the benefits of the therapies outweigh the risks. The FDA said existing clinical experience and improved understanding of managing severe side effects, such as cytokine release syndrome and neurologic toxicities, mean the products can be safely administered without the REMS r
Putting Patients First Blog
JUNE 30, 2025
Pride Month: Recognizing NHC Members Advocating for LGBTQ+ Health Care June 30, 2025 By: Lindsay Marcal, Director, Membership This Pride Month, the National Health Council (NHC) recognizes the efforts of our members to reduce barriers to health care and advance health equity, including for the LGBTQ+ community. As we celebrate Pride, we also recognize the continued challenges that LGBT people face in managing chronic conditions and accessing care.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
JUNE 30, 2025
The FDA has approved Sobi's Gamifant (emapalumab) to treat adults and children with HLH/MAS associated with Still’s disease, including sJIA.
The Pharmacist
JUNE 30, 2025
Almost three-quarters (74%) of pharmacy owners in England have said their business is spending ‘longer than ever before’ to procure medicines amid worsening supply issues, a survey has revealed. Community Pharmacy England’s 2025 annual pressures survey has added weight to ongoing concerns over medicines supply challenges and the impact this is having on both the […] The post Pharmacies spending ‘longer than ever’ managing medicines supply issues appeared first on The Pharmacist.
Pharmaceutical Commerce
JUNE 30, 2025
In the fourth part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, explains the lessons pharma leaders in traditional therapeutic areas can learn from CGT’s highly specialized operational strategies, particularly in terms of supply chain resilience and adaptability.
Express Pharma
JUNE 30, 2025
The nontuberculous mycobacteria (NTM) market across the seven major markets (7MM*) is forecast to grow at a compound annual growth rate (CAGR) of 8.8 per cent from $2.0 billion in 2023 to $4.6 billion in 2033, according to GlobalData. GlobalData’s latest report, “Nontuberculous Mycobacteria (NTM): Opportunity Assessment and Forecast”, reveals that market growth will primarily be driven by the launch of several novel pipeline agents, as well as the projected increase in the number of diagnosed pr
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert insights. Personalized for you.
363 
Let's personalize your content